Updated entrectinib data from a phase 1/2 trial in children and adolescents with recurrent or refractory solid tumors, including primary central nervous system (CNS) tumors Meeting Abstract
| Authors: | Desai, A. V.; Robinson, G. W.; Basu, E. M.; Foster, J.; Gauvain, K.; Sabnis, A. J.; Macy, M. E.; Maese, L.; Yoon, J.; Cash, T.; Abdelbaki, M. S.; Nazemi, K. J.; Weiss, B.; Chohan, S.; Cardenas, A.; Hutchinson, K. E.; Bergthold, G.; Gajjar, A.; Fox, E. |
| Abstract Title: | Updated entrectinib data from a phase 1/2 trial in children and adolescents with recurrent or refractory solid tumors, including primary central nervous system (CNS) tumors |
| Meeting Title: | 52nd Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 67 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 14-17 |
| Meeting Location: | Virtual |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2020-12-01 |
| Start Page: | S122 |
| Language: | English |
| ACCESSION: | WOS:000581769200255 |
| PROVIDER: | wos |
| PUBMED: | 33049088 |
| DOI: | 10.1002/pbc.28742 |
| Notes: | Meeting Abstract: 0259 / #842 -- Source: Wos |
